epidemiology; gastro-oesophageal reflux disease; utilization of medical resources
Abstract :
[en] Background Gastro-oesophageal reflux disease (GORD) is a frequently occurring disease that may be considered a public health issue, particularly in developed countries. The specificity of heartburn for the diagnosis of GORD is good. Our aim was to define the prevalence of heartburn in Belgium, characterizing both its impact on everyday life and the ensuing use of medical resources. Methods Two thousand people living in Belgium, selected randomly after stratification, were interviewed face to face. The main question in the questionnaire used in this interview concerned the presence over the previous 12 months of a burning sensation in the epigastric and/or retrosternal region. This was followed by 21 secondary questions on the characteristics of the population studied, the impact of heartburn on everyday life, and the medical resources used. Results Twenty-eight per cent of the population interviewed reported heartburn. This symptom was present at least once a week in 42% of sufferers. Heartburn was more frequent in women than men (P < 0.05) and was not distributed uniformly throughout the various regions of the country (P < 0.05). Seventy-seven per cent of the people with heartburn found that it had a significantly negative impact on their daily lives (in 27%, this effect was strong). Heartburn associated with a substantial negative impact on daily life was characterized by a higher frequency of symptoms (P < 0.0001), a longer duration of the problem (P= 0.006), and the presence of pain (P < 0.0001) and anxiety (P < 0.0001). Fifty-six per cent of individuals with heartburn had already sought medical advice, 45% had undergone an upper-gastrointestinal tract endoscopy, and 59% were taking medications. Among patients complaining that heartburn had a substantial negative effect on their everyday lives, 21.6% had not sought medical advice and 22.2% did not take any medication. Conclusion Heartburn is very frequent in Belgium and is associated with a considerable negative impact on everyday life. It also generates a significant use of medical resources. However, among the patients complaining of a substantial negative effect on their daily lives, one-fifth (which would represent 1.5% of the Belgian population) seemed to lack appropriate care.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Louis, Edouard ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie
DeLooze, D.
Deprez, P.
Hiele, M.
Urbain, D.
Pelckmans, P.
Deviere, J.
Deltenre, M.
Language :
English
Title :
Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources
Publication date :
March 2002
Journal title :
European Journal of Gastroenterology and Hepatology
ISSN :
0954-691X
eISSN :
1473-5687
Publisher :
Lippincott Williams & Wilkins, Philadelphia, United States - Pennsylvania
Wiklund I., Bardham K., Müller-Lissner S., Bigard M., Bianchi-Porro G., Ponce J. (1998) Quality of life during acute and intermittent treatment of gastro-esophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. Ital J Gastroenterol Hepatol 30:19-27.
Revicki D., Wood M., Maton P., Sorensen S. (1998) The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 104:252-258.
Bruley des Varannes S., Galmiche J.P., Bernades P., Bader J.P. (1988) Douleurs épigastriques et régurgitations. Epidémiologie descriptive dans un échantillon représentatif de la population française adulte. Gastroenterol Clin Biol 12:721-728.
Locke G.R., Talley N.J., Fett S.L., Zinmeister A.R., Melton L.J. (1997) Prevalence and clinical spectrum of gastro-esophageal reflux: A population-based study in Olmsted County, Minnesota. Gastroenterology 112:1448-1456.
Glose H. (1995) Quality of life and cost of therapy in reflux disease. Scand J Gastroenterol 210(SUPPL.):38-42.
(1999) Reflux gastro-oesophagien de l'adulte: 'Diagnostic et traitement'. Conclusions et recommandations du jury: Texte long. Gastroenterol Clin Biol 23:56-65.
(1999) An evidence-based appraisal of reflux disease management. The Genval Workshop report. Gut 44(SUPPL. 2).
Isolauri J., Laippala P. (1995) Prevalence of symptoms suggestive of gastroesophageal reflux disease in an adult population. Ann Med 27:67-70.
Ruth M., Mansson I., Sandberg N. (1991) The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol 26:73-81.
Petersen H. (1995) The prevalence of gastro-esophageal reflux disease. Scand J Gastroenterol 30(SUPPL. 211):5-6.
Jones R.H., Lydeard S.E., Hobbs F.D., Kenkre J.E., Williams E.I., Jones S.J. (1990) Dyspepsia in England and Scotland. Gut 31:401-405.
Deltenre M., Cappelle M., Van Wilder Ph., Jonas C., De Koster E. (1998) Heartburn in Belgium: A population-based epidemiological study. Gastroenterology 114.
Nebel O.T., Formes M.F., Castell D.O. (1976) Symptomatic gastro-esophageal reflux: Incidence and precipitating factors. Dig Dis Sci 21:953-956.
Gallup survey on heartburn across America, Princeton, NJ: The Gallup Organization, Inc.; 1988.
Thompson W.G., Heaton K.W. (1982) Heartburn and globus in apparently healthy people. J Can Med Assoc 126:46-48.
DeLooze D., Louis E. (2000) Regional differences in the perception of gastro-esophageal reflux disease (GORD) in Belgium. Acta Gastroenterol Belg 63.
Kay L., Jorgensen T., Jensen K.H. (1994) Epidemiology of abdominal symptoms in a random population: Prevalence, incidence, and natural history. Eur J Epidemiol 10:559-566.
Romero Y., Cameron A.J., Locke G.R., Schaid D.J., Slezak J.M., Branch C.D., Melton L.J. (1997) Familial aggregation of gastro-esophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 113:1449-1456.
Dimenäs E., Glise H., Hallerback B., Hernqvist H., Svedlund J., Wiklund I. (1993) Quality of life in patients with upper gastrointestinal symptoms. Scand J Gastroenterol 28:681-687.
Stacey J., Miocevich M., Sacks G. (1996) The effect of ranitidine (as effervescent tablets) on the quality of life of GORD patients. Br J Clin Pract 50:190-196.